{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:35:50Z","timestamp":1793853350471,"version":"4.6.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T00:00:00Z","timestamp":1723161600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Brain organoids have become a valuable tool for studying human brain development, disease modeling, and drug testing. However, generating brain organoids with mature neurons is time-intensive and often incomplete, limiting their utility in studying age-related neurodegenerative diseases such as Alzheimer\u2019s disease (AD). Here, we report the generation of 3D brain organoids from human fibroblasts through direct reprogramming, with simplicity, efficiency, and reduced variability. We also demonstrate that induced brain organoids from APOE \u03b54 AD patient fibroblasts capture some disease-specific features and pathologies associated with APOE \u03b54 AD. Moreover, APOE \u03b54-induced brain organoids with mutant APP overexpression faithfully recapitulate the acceleration of AD-related pathologies, providing a more physiologically relevant and patient-specific model of familial AD. Importantly, transcriptome analysis reveals that gene sets specific to APOE \u03b54 patient-induced brain organoids are highly similar to those of APOE \u03b54 post-mortem AD brains. Overall, induced brain organoids from direct reprogramming offer a promising approach for more efficient and controlled studies of neurodegenerative disease modeling.<\/jats:p>","DOI":"10.3389\/fnagi.2024.1435445","type":"journal-article","created":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:56:04Z","timestamp":1723179364000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Modeling APOE \u03b54 familial Alzheimer\u2019s disease in directly converted 3D brain organoids"],"prefix":"10.3389","volume":"16","author":[{"given":"Yunkyung","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byounggook","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saemin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jongpil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,8,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-018-0258-4","article-title":"2D versus 3D human induced pluripotent stem cell-derived cultures for neurodegenerative disease modelling.","volume":"13","author":"Centeno","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/dvdy.24662","article-title":"Applications of human brain organoids to clinical problems.","volume":"248","author":"Chen","year":"2019","journal-title":"Dev. Dyn."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","article-title":"Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo.","volume":"23","author":"Chiaradia","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2019.146561","article-title":"Back to the origins: Human brain organoids to investigate neurodegeneration.","volume":"1727","author":"Faravelli","year":"2020","journal-title":"Brain Res."},{"key":"B5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/jnc.12202","article-title":"Alzheimer\u2019s A\u03b242 and A\u03b240 peptides form interlaced amyloid fibrils.","volume":"126","author":"Gu","year":"2013","journal-title":"J. Neurochem."},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19040936","article-title":"Disease modeling using 3D organoids derived from human induced pluripotent stem cells.","volume":"19","author":"Ho","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","article-title":"Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis.","volume":"96","author":"Huynh","year":"2017","journal-title":"Neuron"},{"key":"B8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer\u2019s disease.","volume":"15","author":"Jahn","year":"2013","journal-title":"Dialogues Clin. Neurosci."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s40035-022-00319-9","article-title":"APOE \u03b54-dependent effects on the early amyloid pathology in induced neurons of patients with Alzheimer\u2019s disease.","volume":"11","author":"Kim","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.709091","article-title":"Administration of Bifidobacterium bifidum BGN4 and Bifidobacterium longum BORI improves cognitive and memory function in the mouse model of Alzheimer\u2019s disease.","volume":"13","author":"Kim","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.stemcr.2019.01.020","article-title":"Modeling G2019S-LRRK2 familial Parkinson\u2019s disease in 3D midbrain organoids.","volume":"12","author":"Kim","year":"2019","journal-title":"Stem Cell Rep."},{"key":"B12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/nprot.2015.065","article-title":"A 3D human neural cell culture system for modeling Alzheimer\u2019s disease.","volume":"10","author":"Kim","year":"2015","journal-title":"Nat. Protoc."},{"key":"B13","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","article-title":"APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types.","volume":"98","author":"Lin","year":"2018","journal-title":"Neuron"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.stem.2021.04.004","article-title":"Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer\u2019s patients.","volume":"28","author":"Mertens","year":"2021","journal-title":"Cell Stem Cell"},{"key":"B15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature10202","article-title":"Induction of human neuronal cells by defined transcription factors.","volume":"476","author":"Pang","year":"2011","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41593-019-0352-0","article-title":"In vivo neuronal gene editing via CRISPR\u2013Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer\u2019s disease.","volume":"22","author":"Park","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"5691","DOI":"10.1093\/emboj\/cdf568","article-title":"The cytoplasmic domain of the LDL receptor-related protein regulates multiple steps in APP processing.","volume":"21","author":"Pietrzik","year":"2002","journal-title":"EMBO J."},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1242\/dev.166074","article-title":"Brain organoids: Advances, applications and challenges.","volume":"146","author":"Qian","year":"2019","journal-title":"Development"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093404","article-title":"Modeling cardiovascular diseases with hiPSC-derived cardiomyocytes in 2D and 3D cultures.","volume":"21","author":"Sacchetto","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease.","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1172\/JCI124853","article-title":"APOE4-mediated amyloid-\u03b2 pathology depends on its neuronal receptor LRP1.","volume":"129","author":"Tachibana","year":"2019","journal-title":"J. Clin. Invest."},{"key":"B22","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","article-title":"Individual brain organoids reproducibly form cell diversity of the human cerebral cortex.","volume":"570","author":"Velasco","year":"2019","journal-title":"Nature"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.stemcr.2014.12.002","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors.","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"key":"B24","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5966\/sctm.2012-0043","article-title":"Variability in the generation of induced pluripotent stem cells: Importance for disease modeling.","volume":"1","author":"Vitale","year":"2012","journal-title":"Stem Cells Transl. Med."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1435445\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,9]],"date-time":"2024-08-09T04:56:09Z","timestamp":1723179369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2024.1435445\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,9]]},"references-count":24,"alternative-id":["10.3389\/fnagi.2024.1435445"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2024.1435445","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,9]]},"article-number":"1435445"}}